Friday 6 November 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue: +6.92%
EPS: +3.18%
Free cash flow: +44.7%
Total debt: +3.21%

Quarter to September 2026, against a year earlier

362.28 5.51 −1.50%

Follow LH

Alert me

Market cap: $29.5B
P/E: 29.5×
Fwd P/E: 26.7×
Dividend yield: 0.79%
F-score: 8/9
Altman Z: 3.02
Beneish M: −2.55
Dividend safety: 74/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Labcorp Holdings Inc. (LH) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Labcorp Holdings Inc. (LH) trades at a price to free cash flow of 25.4×. Over the past ten years it has ranged from 7.6× (April 2021) to 34.3× (April 2024); the current reading is higher than 90% of that period. That is below the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/LH/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Labcorp Holdings Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/LH/metrics/price-to-free-cash-flow">Labcorp Holdings Inc. (LH) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	19.4×	(3.22%)
FY2024	20.0×	(27.11%)
FY2023	27.5×	126.74%
FY2022	12.1×	29.59%
FY2021	9.4×	(0.79%)
FY2020	9.4×	(30.00%)
FY2019	13.5×	19.84%
FY2018	11.2×	(5.87%)
FY2017	11.9×	0.34%
FY2016	11.9×	(17.49%)

Period	Price to free cash flow	Change
Sep 2026	21.6×	(2.52%)
Jun 2026	22.2×	27.27%
Mar 2026	17.4×	(10.26%)
Dec 2025	19.4×	1.18%
43 more quarters	Free account

Against its own ten years

Low 7.6× High 34.3×

Ten-year median 13.7×

Current reading's percentile 90

Company	Price to free cash flow
GH Guardant Health, Inc. compare	n/m
DGX Quest Diagnostics Incorporated compare	20.3×
IQV IQVIA Holdings Inc. compare	21.0×
LH Labcorp Holdings Inc.	25.4×
MEDP Medpace Holdings, Inc. compare	26.6×
ILMN Illumina, Inc. compare	30.4×
A Agilent Technologies, Inc. compare	38.2×
MTD Mettler-Toledo International, Inc. compare	39.1×
WAT Waters Corporation compare	173×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Labcorp Holdings Inc. (LH) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on LH

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on LH

Stockrow Weekly